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Daptomycin is a clinically important 13 amino acid lipopeptide antibiotic. Its
N-terminus is acylated with n-decanol and its C-terminal 10 amino acids
form a ring. It is structurally and size-wise different from other well-known
membrane-active antimicrobials. Daptomycin is known to disrupt the cytoplas-
mic membrane function of Gram-positive bacteria by causing leakage of potas-
sium (and potentially other) ions, leading to the loss of membrane potential and
cell death. The critical factor affecting the function of daptomycin is its inter-
action with negatively charged lipids such as PG in a calcium (Caþþ) depen-
dent manner. Based on previous research on cell membranes, daptomycin
has been assumed to insert and aggregate in the membrane, and then to alter
the membrane curvature. However these details have not been demonstrated
by biophysical studies. In our aspirated GUV experiments, we found that
with a DOPG-containing GUV and a sufficient concentration of Caþþ, dapto-
mycin can extract lipid molecules, and form lipid-peptide aggregations. The
lipid-peptide aggregates did not occur if cardiolipin replaced PG, or if other
divalent ions, such as Mgþþ, Baþþ replaced Caþþ. Similarly, daptomycin
did not bind to a GUV when cardiolipin substituted for DOPG or in the absence
of Caþþ. Daptomycin with Caþþ did bind to a pure DOPC GUV, but had no
other effects. Furthermore, with the presence of daptomycin, DOPG and
Caþþ, we found Caþþ permeates into the GUV, while a content dye, Texas
red dextran, did not leak out. This result suggests that daptomycin and Caþþ
do not form pores on the membrane of DOPG-contained GUV, but cause leak-
age of ions. Finally, daptomycin with DOPG and Caþþ produces a negative ex-
citon CD couplet centered at the 225 nm absorption peak of Trptophan1 and
Kynurenine13, whereas in all other conditions, the exciton CD couplet is
positive.
3086-Pos Board B241
Amino Acid Sequence and Membrane Binding for a Series of Closely
related Amphipathic Peptides
Antje Pokorny, Melissa A. Cherry, Sarah K. Higgins, Hilary Melroy,
Hee-Seung Lee.
University North Carolina Wilmington, Wilmington, NC, USA.
We have investigated the dependence of peptide activity on the amino acid se-
quence for a series of synthetic peptides derived from d-lysin. d-Lysin is a 26
amino acid, N-terminally formylated, hemolytic peptide that forms an amphi-
pathic a-helix bound at membrane-water interfaces. A shortened peptide,
lysette, was derived from d-lysin by deletion of the 4 N-terminal amino acid
residues. Five variants of lysette were synthesized by altering the amino acid
sequence under the constraint that the overall hydrophobic moment be essen-
tially the same for all peptides. Peptide-lipid equilibrium dissociation constants
and helicities of peptides bound to zwitterionic lipid vesicles were determined
by stopped-flow fluorescence and circular dichroism. We then compared the
thermodynamics of peptide binding calculated using the Wimley-White hydro-
phobicity scale with the experimentally determined free energy of binding. We
found a systematic deviation of the experimentally determined dissociation
constant and that predicted by the Wimley-White scale. Molecular dynamics
simulations suggest two factors that account for the very favorable experimen-
tal binding free energy. (1), in all d-lysin-derived peptides simulated, the initial
bilayer contact is made with the polar peptide face, allowing charged residues
to establish strong interactions with the bilayer headgroup region early on. (2),
if the two aspartate residues contained in the lysette sequences are located at the
C-terminus, they remain exposed to water and are, thus, effectively removed
from the bilayer headgroup region.
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Electrical aspects of the membrane permeabilization by various polycationic
peptides were studied. The peptides were designed on the basis of synthetic
16-mer and 14-mer fragments of the Cry11Bb protoxin by their conjugation
to the cell penetrating hepta-arginine vector trough two glycine residues.
Some of these peptides demonstrated selective killing of human leukemia
Jurkat cells but not of the normal wild type CHO cells. In this respect, the de-
signed peptides were more active than the known anticancer peptide R7-KLA.
The peptides permeabilized the energized mitochondria as well as the red blood
cells with relatively high plasma membrane potential generated in the presence
of valinomycin. The efficiency of the peptides was remarkably higher in the
lower ionic strength media. The capability of the plasma membrane permeabi-lization by the designed peptides was strongly potentiated by the external high
voltage electrical pulses applied to the cell suspension. Similar effect was
observed using the planar lipid membrane, demonstrating that the formation
of peptide pores in the lipid bilayer is highly increased by an increase in the
applied transmembrane potential (minus at the trans-side). The obtained results
open the perspective of the local destruction of solid tumors using the combined
‘‘peptide-electrical pulses’’ synergistic treatment. Colciencias (Colombia) re-
search grants #111840820380 and #111852128625.
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Amphipathic peptides bind to the outer leaflet of membrane bilayers. Do they
translocate across the membrane? The answers are directly related to their func-
tions in the case of cell-penetrating peptides and drugs, or to their mechanisms
in the case of AMPs. To our knowledge, few permeability experiments have
been performed so far, probably because of the difficulty of detecting the pep-
tides and also because a meaningful test must be conducted at biologically rel-
evant concentrations which are usually low. In the case of pore forming
peptides, the test must be performed without pore formation. Here we demon-
strate a membrane permeation experiment for a peptide drug NYAD-1 (an
HIV-1 inhibitor). There are several factors that make this experiment possible.
We used a FITC labeled peptide called NYAD-2 for the peptide detection. We
discovered that it is possible to produce GUVs in pH 9, although not in pH 7.
We found that the intensity of FITC in pH 9 is 1.7 times higher than in pH 7. By
using an aspirated GUV, we measured the relative binding coefficients of
NYAD-2 to the GUV in pH 7 and pH 9, and found that the former is 2 to 3 times
higher than the latter. With all these provisions, we performed the permeability
test by transferring an aspirated GUV produced in pH 9 solution containing
Texas red dextran (TRD) MW 625 to a solution of pH 7 containing 2 micro-
Mole NYAD-2. We found the concentration of NYAD-2 inside the GUV in-
creased with time while the membrane remained intact and there was no leak-
age of TRD. We are able to extend this method to test the membrane
permeability of other peptides and drugs such as Melittin.
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Antimicrobial peptides are short, cationic, amphiphilic naturally occurring se-
quences that have selective antimicrobial properties. The proposed mechanism
of action for these peptides is through interaction with and disruption of the
bacterial membrane. We have investigated the length and amino acid compo-
sition dependence of the antimicrobial peptides ponericin L1 and C18G on an-
timicrobial activity and membrane binding ability. Truncation of the peptide
sequence at different points through synthesis allowed for investigation of
length, overall hydrophobicity, and net charge on function. Circular dichroism
and fluorescence spectroscopy were used to determine the binding affinity and
structure of the peptide in the presence of lipid vesicles. All of the L1 derived
peptides exhibited the ability to form alpha helices and bind to the lipid mem-
branes to different degrees. The data suggests that the modified peptide (L1A)
and the truncated peptides (L1A-13T, L1A-16T, and L1A-21T) work by form-
ing an alpha helix to permeabilize the bacterial membrane and cause bacteriol-
ysis. Alternatively, the C18G derived truncates exhibited a length threshold in
their ability to bind membranes with high affinity and form helical structures.
Ongoing experiments are probing membrane topography.
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It is important to understand how AMPs interact with human cells for develop-
ment of antimicrobial agents of systemic use or anticancer drugs. However, litte
is known about the mechanisms by which AMPs bind to them and exert cyto-
toxicity. Negatively charged gangliosides on cell surface are a potential target
for cell binding. [1] In this study, we investigated the interaction of MG2 (F5W-
magainin 2) with gangliosides in detail. MG2 was colocalized with ganglio-
sides on HeLa cells, indicating that gangliosides act as a receptor for MG2.
Physicochemical studies using liposomes revealed that MG2 interacts with
monosialoganglioside GM1 differently from the typical bacterial anionic lipid
phosphatidylglycerol (PG). MG2 bound to GM1 more strongly than to PG, and
the bindig isotherm for GM1 could be analyzed by the Langmuir equation as-
suming the charge neutralization. This makes a contrast to the binding of AMPs
